{"id":"https://openalex.org/W4281779225","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271","title":"Real-world data comparing FOLFIRINOX versus gemcitabine nab-paclitaxel as first-line treatment of metastatic pancreatic ductal adenocarcinoma patients in the United States.","display_name":"Real-world data comparing FOLFIRINOX versus gemcitabine nab-paclitaxel as first-line treatment of metastatic pancreatic ductal adenocarcinoma patients in the United States.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281779225","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e16271","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008076450","display_name":"Avital Klein-Brill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Avital Klein-Brill","raw_affiliation_strings":["Anthem Innovation Israel, Tel Aviv, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anthem Innovation Israel, Tel Aviv, Israel;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017206938","display_name":"Shlomit Amar-Farkash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shlomit Amar-Farkash","raw_affiliation_strings":["Anthem Innovation Israel, Tel Aviv, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anthem Innovation Israel, Tel Aviv, Israel;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110648438","display_name":"Gabriella M. Lawrence","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriella Lawrence","raw_affiliation_strings":["Anthem Innovation Israel, Tel Aviv, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anthem Innovation Israel, Tel Aviv, Israel;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035793503","display_name":"Eric Andrew Collisson","orcid":"https://orcid.org/0000-0001-8037-9388","observed_orcids":["https://orcid.org/0000-0001-8037-9388","https://orcid.org/0000-0002-2829-355X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Andrew Collisson","raw_affiliation_strings":["University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090643981","display_name":"Michael Jordan Fisch","orcid":"https://orcid.org/0000-0001-5312-403X","observed_orcids":["https://orcid.org/0000-0001-5312-403X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Jordan Fisch","raw_affiliation_strings":["AIM Specialty Health, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIM Specialty Health, Chicago, IL;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043515714","display_name":"Dvir Aran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Dvir Aran","raw_affiliation_strings":["Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion-Israel Institute of Technology, Haifa, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion-Israel Institute of Technology, Haifa, Israel;","institution_ids":["https://openalex.org/I174306211"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e16271","last_page":"e16271"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-pancreatic-ductal-adenocarcinoma","display_name":"metastatic pancreatic ductal adenocarcinoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/folfirinox","display_name":"FOLFIRINOX","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gemcitabine-plus-nab-paclitaxel","display_name":"gemcitabine plus nab-paclitaxel","score":0.9390000104904175},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8460000157356262},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.953000009059906},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.6769999861717224},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.7089999914169312},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5019999742507935},{"id":"https://openalex.org/keywords/socioeconomic-inequality","display_name":"socioeconomic disparities","score":0.414000004529953},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.6990000009536743},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6840000152587891},{"id":"https://openalex.org/keywords/metastatic-sites","display_name":"metastatic sites","score":0.890999972820282},{"id":"https://openalex.org/keywords/american-patients","display_name":"United States patients","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.924369215965271},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.8342603445053101},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6504464149475098},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6479648351669312},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.596562385559082},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.5616788268089294},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4942934513092041},{"id":"https://openalex.org/C2779804826","wikidata":"https://www.wikidata.org/wiki/Q45435667","display_name":"Folinic acid","level":4,"score":0.47334054112434387},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3269888162612915},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.24802619218826294},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.1079995334148407},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e16271","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16271","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282919273","https://openalex.org/W7162694471","https://openalex.org/W2791279584","https://openalex.org/W2606873218","https://openalex.org/W2890376061","https://openalex.org/W4281396000","https://openalex.org/W3188489262","https://openalex.org/W7165165606","https://openalex.org/W4280626776","https://openalex.org/W4205731320"],"abstract_inverted_index":{"e16271":[0],"Background:":[1],"The":[2],"common":[3],"first-line":[4],"therapies":[5],"for":[6,115,187],"metastatic":[7,122,214],"adenocarcinoma":[8],"of":[9,55,71,74,107,199,242,275],"the":[10,47,87,131,179,269],"pancreas":[11],"(mPC)":[12],"are":[13,40],"FOLFIRINOX":[14,57,147,236,276],"and":[15,32,52,80,124,149,169,184,190,213,224,248,271],"gemcitabine":[16],"plus":[17],"nab-paclitaxel":[18],"(Gem-Nab-P).":[19],"However,":[20],"these":[21,261],"treatments":[22,264],"have":[23],"not":[24],"been":[25],"directly":[26],"compared":[27],"in":[28,60,171],"a":[29,67],"clinical":[30],"trial":[31,259],"comparative":[33],"real-world":[34,43],"data":[35,85],"analyses":[36],"on":[37,49],"their":[38],"effectiveness":[39],"limited.":[41],"Using":[42],"data,":[44],"we":[45],"evaluated":[46],"impact":[48],"overall":[50,94],"survival":[51,95,197,241,270],"post-treatment":[53,221,226,272],"hospitalizations":[54,222],"1L":[56,72,140],"vs.":[58],"Gem-Nab-P":[59,154,247],"individuals":[61],"with":[62,76,146,153,161,173,239,252],"mPC.":[63],"Methods:":[64],"We":[65],"performed":[66],"retrospective":[68,231],"cohort":[69,137,232],"study":[70,233],"treatment":[73,108],"patients":[75,157,189,217],"mPC":[77,141],"between":[78],"1/2015":[79],"6/2020,":[81],"utilizing":[82],"administrative":[83],"claims":[84],"from":[86,101],"Anthem":[88],"Cancer":[89],"Care":[90],"Quality":[91],"Program.":[92],"Real-world":[93],"(rwOS)":[96],"was":[97,111,128,182,201],"defined":[98],"as":[99],"time":[100],"diagnosis":[102],"to":[103,113,267],"death.":[104],"Inverse":[105],"probability":[106],"weighting":[109],"(IPTW)":[110],"used":[112],"adjust":[114],"age,":[116],"ECOG,":[117],"Socioeconomic":[118],"index":[119,212],"(SDI),":[120],"comorbidity,":[121],"sites":[123],"pre-treatment.":[125],"Median":[126,180],"rwOS":[127,181],"estimated":[129],"using":[130],"weighted":[132],"Kaplan-Meier":[133],"method.":[134],"Results:":[135],"Our":[136,230],"included":[138],"1,102":[139],"patients,":[142],"566":[143],"(51.4%)":[144],"treated":[145,152],"(F),":[148],"536":[150],"(48.6%)":[151],"(GNP).":[155],"F-treated":[156,216],"were":[158],"generally":[159],"younger,":[160],"better":[162],"performance":[163],"status":[164],"(ECOG":[165],"PS),":[166],"fewer":[167,220,253],"comorbidities":[168],"living":[170],"regions":[172],"higher":[174],"socioeconomic":[175,211],"index.":[176],"Following":[177],"adjustments,":[178],"9.28":[183],"6.82":[185],"months":[186,245],"F-initiated":[188],"GNP,":[191],"respectively":[192],"(p-value":[193],"=":[194],"2.5e-07).":[195],"This":[196],"benefit":[198,274],"F":[200],"observed":[202],"among":[203],"all":[204],"sub-groups,":[205],"including":[206],"different":[207],"ECOG":[208],"PS,":[209],"ages,":[210],"sites.":[215],"also":[218,250],"had":[219],"(p-value=0.027)":[223],"lower":[225],"costs":[227],"(p-value=0.00004).":[228],"Conclusions:":[229],"demonstrated":[234],"that":[235],"is":[237,249,265],"associated":[238,251],"improved":[240],"approximately":[243],"2":[244],"over":[246,277],"post-treatments":[254],"complications.":[255],"A":[256],"randomized":[257],"controlled":[258],"comparing":[260],"first":[262],"line":[263],"warranted":[266],"test":[268],"complications":[273],"Gem-Nab-P.[Table:":[278],"see":[279],"text]":[280]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2022-06-13T00:00:00"}